Bruker Corporation BRKR delivered adjusted earnings per share (EPS) of 76 cents for the fourth quarter of 2024, up 8.6% year ...

Frank Laukien; Chairman of the Board, President, Chief Executive Officer; Bruker Corp Gerald Herman; Chief Financial Officer, Executive Vice President; Bruker Corp Good day, and welcome to the Bruker ...

Corporation reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $0.76 against the forecast of $0.74. Revenue also exceeded projections, ...

Researchers at the University of Oxford and their collaborators, including the Serum Institute of India, have developed an innovative method to identify falsified vaccines without opening the vaccine ...

Reaction products with different degrees of functionalization were analyzed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Additional gradient elution ...

Bruker ’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and its ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...

Bruker Corporation (NASDAQ: BRKR) is undervalued, trading below its fair value of $74, offering significant upside potential due to its strategic acquisitions and improving book value per share ...

Integration with Bruker’s MALDI Imaging methods enable multimodal imaging to characterize tissues with enhanced analytical depth. The LUMOS II ILIM can also be used for rapid ...

A recent development in the spatial biology arena is Bruker’s neofleX TM MALDI-TOF system. The neofleX is a multiomics MSI system that enables the analysis of proteins, glycans, lipids, peptides and ...

MALDI imaging mass spectrometry (IMS) is chemical imaging of lipids, endogenous peptides and small proteins with 5um spatial resolution. The image above shows localization of lipids in the brain. Left ...